Yousif Capital Management, LLC Supernus Pharmaceuticals, Inc. Transaction History
Yousif Capital Management, LLC
- $8.31 Billion
- Q1 2025
A detailed history of Yousif Capital Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 20,727 shares of SUPN stock, worth $666,373. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,727
Previous 21,231
2.37%
Holding current value
$666,373
Previous $767,000
12.78%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$198 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$167 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$93.4 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$86.8 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.72B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...